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The prevalence of type 2 diabetes (T2DM) continues to rise in epidemic proportions both in the 
U.S. and globally [1]. Currently within the U.S., T2DM accounts for greater than 90% of all 
diabetes cases and is over-represented among ethnic minority and other underserved populations, 
including the rural Appalachian region [2, 3].  As a region, rural Appalachian counties 
experience greater burdens of poverty, income inequality, and unemployment compared to non-
Appalachian U.S. counties [4, 5] and exceed state and national averages.  
 
Poverty, socioeconomic stress and consequent unhealthy lifestyles have been shown to increase 
the risk for the development of obesity and T2DM as well as morbidity and premature mortality 
of T2DM [6-10].  Recent data have demonstrated higher rates of self-reported T2DM (11.3%) in 
Appalachian Ohio compared to the general population, rivaling rates found among ethnic 
minority communities [2].  Individuals with diabetes in this region reported a two-fold higher 
prevalence of heart disease and a three-fold higher prevalence of stroke compared to non-
diabetes individuals [2]. 
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Impact of Co-Morbid Depression 
Patients with T2DM have been found to be two times more likely to experience depressive 
symptoms than their non-diabetes peers [11]. The aggregated lifetime prevalence of major 
depression has been found to range between 11.4% and 27%, with greater rates found in studies 
using depression questionnaires [11]. 
Depressive symptoms have been shown to have negative consequences for individuals with 
diabetes.  Depression has been shown to be associated with worsened blood glucose levels [12] 
and diabetes complications [13] such as coronary heart disease (CHD) [14].  Depression is also 
associated with decreased adherence to self-care regimens, increased medical costs associated 
with greater depression severity and greater ambulatory care use and prescription costs [15-17] 
in individuals with diabetes. 
Despite the significant costs of co-morbid depression and diabetes, relatively few controlled 
depression treatment trials have been conducted.  The majority of trials have demonstrated the 
efficacy of medication treatment [19-24]. Lustman and colleagues conducted the benchmark 
randomized controlled trial for cognitive behavioral therapy (CBT) in patients with co-morbid 
depression and diabetes [18]. In this study, 51 patients diagnosed with T2DM and major 
depression were randomly assigned to a 10-week individualized CBT or control condition 
without medication intervention. Findings showed 71% of patients receiving CBT compared to 
22% of patients in the control group achieved depression remission at post-treatment assessment. 
At 6-month follow-up assessments, depression remitted in 67% of patients in the CBT condition 
compared to 30% in the control group [18].  In addition, clinically significant reductions in 
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average blood glucose (HbA1c) were found among those in the CBT condition at 6 month 
follow-up assessment. 
No studies to date have examined the effectiveness of aerobic exercise as a treatment for major 
depression in patients with diabetes, although a variety of studies have demonstrated 
antidepressant effects of exercise in patients with clinical depression [25-28].  In randomized 
clinical trials, exercise was shown to be as effective as antidepressant medications in treating 
depression with the benefits of exercise extending beyond those observed in medication alone 
[25-26].  
Finally, exercise interventions have been shown to improve glycemic control in patients with 
T2DM [29-35]. Exercise training has also been shown to result in the reduction of a variety of 
cardiovascular risk factors including:  upper-body visceral adiposity [30], improvement 
in  insulin sensitivity [31], increase in high density lipoprotein cholesterol [HDL-C; [32-33], 
reduction of triglycerides, increased LDL particle size, reduction of  hypertension, and decreased 
total cholesterol [35-39]. 
Taken together, there is mounting evidence for the need to develop effective and accessible 
depression treatment for individuals with T2DM and depression.  Program ACTIVE 
(Appalachians Coming Together to Increase Vital Exercise) was designed to test the 
effectiveness of a combination behavioral approach to the treatment of depression in adult 
patients with T2DM, living in the Appalachian region, on depression, glycemic and 
cardiovascular risk outcomes.  The study received Institutional Review Board approval from 
Ohio University. 
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The primary study aims were:  
1. To assess the feasibility of recruitment, retention, and adherence of an at-risk 
Appalachian T2DM sample with major depression to a 12-week interdisciplinary 
depression treatment protocol combining CBT and community-based exercise; 
2. To assess changes in depression following intervention (POST) and 3-month follow-up 
(3MFU) assessments compared to baseline. 
3. To assess changes in glycemic control at POST and at the 3MFU assessments. 
4. To assess changes in blood lipids as an index of cardiovascular risk, at POST and 
3MFU.  Maximal aerobic capacity (VO2 max), exercise tolerance, and resting blood 
pressure were evaluated at POST and 3MFU assessments. 
The secondary aims of Program ACTIVE were to assess changes in quality of life and social 
support at POST and 3MFU compared to baseline. 
Study Design 
Program ACTIVE was a single-arm repeated measures intervention study conducted in two 
phases. In Phase I, a culturally consonant CBT manual was created. Exercise protocol materials 
based on the Diabetes Prevention Program [DPP; 40] were culturally-tailored for a rural 
Appalachian population with T2DM.  All materials were evaluated for cultural salience, 
readability and comprehension by key informants drawn from the community and national 
consultants (de Groot, et al., In preparation).  
In Phase II, the interdisciplinary treatment protocol was implemented. Participants were recruited 
from the community through direct physician referral and community advertisement. Participants 
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were screened by phone for initial study inclusion before completing a baseline assessment 
protocol. Participants who met eligibility criteria during baseline assessment were enrolled in the 
intervention.  Participants completed follow-up assessments immediately following the 
intervention (POST) and 3 months following intervention completion (3MFU). 
Recruitment 
Participants for Program ACTIVE were recruited from communities in southeastern Ohio and 
western West Virginia.   In order to ensure participant safety, the following eligibility criteria 
were used: age 18 or older, ability to engage in walking or other physical activity, diagnosis of 
T2DM for one year duration or longer, and a current diagnosis of major depression with no 
evidence of psychotic symptoms. Individuals were excluded from participation if they were 
diagnosed with current or recent medical events that would preclude safe participation in 
moderate intensity physical activity (e.g. uncontrolled hypertension, medical instability, recent 
cardiac events, etc.) or met criteria for psychiatric disorders not addressed by the intervention 
(e.g. bipolar disorder). 
A total of N=336 individuals were screened by phone to assess medical and psychiatric 
eligibility.  Twenty-three percent (N=65) of these individuals met eligibility criteria and were 
referred for baseline assessment.  Of these, N=50 (77%) individuals were enrolled in the 
intervention. 
Assessment Procedure 
Psychological, behavioral and physiologic measures were administered at each of the three 
assessment periods: baseline, immediately following the intervention (POST) and 3-month 
5 
 
follow-up assessment (3MFU).  Psychological and behavioral measures included:  demographic 
questionnaire; the Structured Clinical Interview for the DSM-IVTR [41,42] used to assess 
lifetime and current diagnoses of Axis I disorders;  Beck Depression Inventory (BDI-II) used to 
assess symptoms of depression [43];  Diabetes Quality of Life Measure (DQOL) used to assess 
diabetes-specific quality of life [45]; SF-36 Quality of Life Measure (SF-36)used to assess 
general quality of life [45]; Chronic Illness Resource Survey (CIRS) used to assess social support 
using an ecological lens [46]; Physical Activity Diaries adapted from the DPP Lifestyle Balance 
Intervention condition [40] used to record physical activity for a one-week period at each 
assessment and weekly throughout the 12-week intervention period;  and Number of Steps were 
measured during a one-week period at each assessment and throughout the intervention [47]. 
Physiologic measures included: body mass index (BMI), glycated hemoglobin (HbA1c); fasting 
blood lipids including HDL-C, total cholesterol, LDL-C (direct), and triglycerides. The maximal 
graded exercise test (GXT)was utilized to assess maximal aerobic capacity and exercise 
tolerance at the baseline and POST assessments. In addition, resting, exercise and recovery blood 
pressures and heart rate, and the Perceived Exertion (Borg Scale) were measured during the GXT 
to determine perceived stress during aerobic exercise training.  Self-monitored blood glucose 
(SBMG) data was gathered from One-Touch SMBG monitors by participants throughout the 
study period.  
Intervention Design 
The interdisciplinary intervention was composed of 10 manualized CBT sessions, six exercise 
classes with supervised exercise, and 12 weeks of community-based aerobic activity.  These 
interventions were administered concurrently in order to assess the feasibility of recruiting and 
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retaining participants in this demanding combination treatment protocol.  CBT sessions were 
conducted by trained advanced graduate students in the doctoral program in clinical psychology 
at Ohio University. Sessions were scheduled weekly over the course of the 12-week period, with 
two weeks available for flexibility in scheduling due to holidays or vacations as needed. The 
community-based exercise was conducted throughout the 12-week period.  An exercise manual, 
free access to a community exercise facility, and weekly contact with study personnel were 
provided to participants to encourage adherence to the exercise protocol, collect activity data, 
and review participant safety and changes to medical status.  
Exercise goals were adapted to accommodate the physical and medical restrictions of an older-
adult diabetes population.  Exercise prescriptions were based on the results obtained from the 
GXT at baseline. Participants were given exercise goals that represented a total duration of 150 
minutes per week with activity that reached 50 to 85% maximum heart rate consistent with the 
American College of Sports Medicine recommendations [48, 49]. Due to the limited prior 
exercise experience of participants as well as the unique needs of patients with depression and 
diabetes, exercise duration and intensity goals were increased in a graduated fashion during 
Weeks 1-3, beginning with 100 minutes of weekly exercise  and increasing to 150 minutes of 
total weekly exercise. Participants were asked to complete weekly exercise diaries and to record 
number of steps measured using pedometers during the intervention period (Weeks 1-12). 
Results 
Analysis of demographic characteristics of the total sample (N=50) enrolled in the intervention 
indicated that participants had a mean age of 57 (S.D. 9.0) years.  The sample was predominantly 
female (68%), married (74%), and evenly distributed across educational levels with a modal 
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annual household income of $21,000-40,000. The mean duration of T2DM was 11.0 (S.D. 7.0) 
years.  The mean BMI was 35.1 (S.D. 7.1). 
Using intent-to-treat analyses, 66% of participants no longer met criteria for Major Depressive 
Disorder at POST (p<.001) and 65% of participants were remitted at the 3MFU assessment 
(p<.001). Mean Beck Depression Inventory scores improved significantly both at the POST (-
8.8, S.D. 8.9, p<.05) and 3MFU (-8.3, S.D. 10.9, p<.05) assessments.  
With respect to diabetes outcomes, significant decreases in fasting glucose were observed at 
3MFU (M=-21.4 mg/dl, S.D. 43.2, p<.01) as were improvements in LDL-C at POST (M=-11.9, 
S.D. 28.6, p<.01). Average blood glucose levels (HbA1c) decreased by .32% at the POST 
assessment (S.D. 1.0%, p=.05) and .22% at the 3MFU assessment (S.D. 0.9%, p=.10).  
Evaluation of exercise outcomes from the GXT procedure showed increased participant capacity 
for exercise at the POST assessment compared to baseline (VO2 peak M=0.08 L/min, S.D. 0.2, 
p<.05).  Participants completed 193 min/wk of aerobic activity (range: 76-478) during the 
intervention, exceeding the graduated study goal of 150 minutes/week.  Self-reported physical 
activity improved significantly from baseline to POST (11.9, S.D. 18.5, p<.01) and 3MFU (10.2, 
S.D. 16.6, p<.01).  Participants reported significant improvements in their confidence to perform 
regular physical activity at POST compared to their baseline values (M=5.9, S.D. 13.6, p<.05). 
Finally, evaluation of diabetes-specific quality of life and social support from baseline to POST 
and 3MFU assessments showed significant improvements. 
Conclusions 
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Program ACTIVE demonstrated positive outcomes associated with a rigorous combination 
behavioral approach to the treatment of depression tailored for individuals living in the rural 
Appalachian region.  Rates of depression remission are comparable to previous studies using 
single strategy approaches (i.e. CBT, medication, or exercise alone [18, 25]).  Improvements in 
diabetes and exercise outcomes also demonstrated the value of a combination treatment approach 
for depression, diabetes and cardiovascular risk factors.  Moreover, participants reported 
improvements in quality of life and social support following this demanding intervention.   
Barriers endemic to this region such as large geographic distances between place of residence 
and community facilities, gas price vulnerability, and caregiver demands for family members 
were identified by participants as pertinent to recruitment and retention in the depression 
treatment protocol.  Participants identified the need for a network of community partners to 
provide participants with affordable and convenient exercise outlets and cognitive behavioral 
therapy. Intervention programs such as Program ACTIVE can be successful in improving 
depression and diabetes outcomes in spite of these barriers if they are flexible in their approach 
and make use of community resources to facilitate participant self-care.  In so doing, there is 
great opportunity to address the significant costs associated with co-morbid depression and 
diabetes and to improve the quality of life of residents of this underserved region. 
Funding for this study was provided by the National Institutes of Health R34DK71545, Ohio 
Department of Health, Office of Healthy Ohio, Bureau of Health Promotion and Risk Reduction, 
Diabetes Prevention and Control Program and the Ohio University Diabetes Research 
Initiative.  This research was conducted with support from the Investigator-Initiated Study 
Program of Lifescan, Inc. 
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